Wire Stories

Takeda Receives Complete Response Letter from the U.S. FDA for TAK-721

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it…

Mawari Uses AWS Wavelength to Build 3DXR Content Streaming Platform

Digital Human as a Service (DHaaS) is Born TOKYO & SAN JOSE, Calif.--(BUSINESS WIRE)--Mawari, a…

ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill

ExThera and Asahi Kasei Medical secure exclusive distribution agreement in Japan MARTINEZ, Calif.--(BUSINESS WIRE)--ExThera Medical…

Desktop Metal and the Korea Institute of Industrial Technology Partner to Accelerate the Adoption of Metal Binder Jetting for SMEs in South Korea

Installations of Desktop Metal’s Production System and Shop System Platforms Will Catalyze the Innovation, Development…

Desktop Metal and the Korea Institute of Industrial Technology Partner to Accelerate the Adoption of Metal Binder Jetting for SMEs in South Korea

Installations of Desktop Metal’s Production System and Shop System Platforms Will Catalyze the Innovation, Development…

Desktop Metal and the Korea Institute of Industrial Technology Partner to Accelerate the Adoption of Metal Binder Jetting for SMEs in South Korea

Installations of Desktop Metal’s Production System and Shop System Platforms Will Catalyze the Innovation, Development…

Propanc Biopharma Demonstrates Significant Effects of Proenzyme Therapy on the Tumor Microenvironment

Chief Scientific Officer Concludes Observations Applicable to All Solid Tumors MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc.…

Propanc Biopharma Demonstrates Significant Effects of Proenzyme Therapy on the Tumor Microenvironment

Chief Scientific Officer Concludes Observations Applicable to All Solid Tumors MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc.…

Propanc Biopharma Demonstrates Significant Effects of Proenzyme Therapy on the Tumor Microenvironment

Chief Scientific Officer Concludes Observations Applicable to All Solid Tumors MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc.…

CyberLink to Showcase the Latest Game-Changing Applications of its FaceMe® AI Facial Recognition Solution at CES 2022

CES attendees invited to visit Booth 9543 in the North Hall to learn about FaceMe®…